Estimating the causal effects of cumulative treatment episodes for adolescents using marginal structural models and inverse probability of treatment weighting

Drug and Alcohol Dependence

Volumn 136, Issue 1, 2014, Pages 69-78

  Griffin, Beth Ann ^a   Ramchand, Rajeev ^a   Almirall, Daniel ^b   Slaughter, Mary E ^a   Burgette, Lane F ^a   McCaffery, Daniel F ^a  

^a RAND CORPORATION   (United States)

^b Institute for Social Research   (United States)

Author keywords

Adolescent treatment; Cumulative treatment effects; Generalized boosted model; Inverse probability of treatment weights; Marginal structural model; Time varying confounding

Indexed keywords

ADOLESCENT TREATMENT; CUMULATIVE TREATMENT EFFECTS; GENERALIZED BOOSTED MODEL; INVERSE-PROBABILITY-OF-TREATMENT WEIGHTS; MARGINAL STRUCTURAL MODEL; TIME-VARYING CONFOUNDING;

ADOLESCENT; ALGORITHMS; AMBULATORY CARE; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; RESIDENTIAL TREATMENT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 84893755428     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.12.017     Document Type: Article

References (52)

1. Almirall D., Griffin B.A., McCaffrey D.F., Ramchand R., Yuen R.A., Murphy S.A. Time-varying effect moderation using the structural nested mean model: estimation using inverse-weighted regression with residuals. Stat. Med. 2013, (in press).
2. Almirall D., McCaffrey D.F., Ramchand R., Murphy S.A. Subgroups analysis when treatment and moderators are time-varying. Prev. Sci. 2013, 14:169-178.
3. Almirall D., Ten Have T., Murphy S.A. Structural nested mean models for assessing time-varying effect moderation. Biometrics 2010, 66:131-139.
4. Anglin M.D., Hser Y.I., Chou C. Reliability and validity of retrospective behavioral self-report by narcotics addicts. Eval. Rev. 1993, 17:91-108.
5. Burgette L., Griffin B.A., McCaffrey D.F. Propensity Scores for Multiple Treatments: A Tutorial for the MNPS Function in the Twang Package. R package 2013, Rand Corporation, Arlington, VA.
6. Burleson J.A., Kaminer Y., Burke R.H. Twelve-month follow-up of aftercare for adolescents with alcohol use disorders. J. Subst. Abuse Treat. 2012, 42:78-86.
7. Chestnut Health Systems Global Appraisal of Individual Needs (GAIN): Overview 2004, Chestnut Health Systems, Bloomington, IL.
8. Chou C.P., Hser Y.I., Anglin M.D. Pattern reliability of narcotics addicts' self-reported data: a confirmatory assessment of construct validity and consistency. Subst. Use Misuse 1996, 31:1189-1216.
9. Dennis M., Godley S.H., Diamond G., Tims F.M., Babor T., Donaldson J., Liddle H., Titus J.C., Kaminer Y., Webb C., Hamilton N., Funk R. The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. J. Subst. Abuse Treat. 2004, 27:197-213.
10. Dennis M.L., Ives M., Funk R., Modisette K., Bledsaw R., Ihnes P. GAIN-I Encyclopedia of Supplemental Documentation on Scales and Other Calculated Variables 2010, Chestnut Health Systems, Bloomington, IL, (accessed 18.6.13). http://www.chestnut.org/LI/gain/Scales_Crosswalks/GI_Scales_and_Variables.xls.
11. Dennis M.L., Scott C.K., Funk R.R., Foss M.A. The duration and correlates of addiction and treatment careers. J. Subst. Abuse Treat. 2005, 28:S51-S62.
12. Dennis M.L., Titus J.C., White M., Unsicker J., Hodgkins D. Global Appraisal of Individual Needs (GAIN): Administration Guide for the GAIN and Related Measures 2003, Chestnut Health Systems, Bloomington, IL, (accessed 1.11.13). http://www.gaincc.org/gaini.
13. Drug Strategies Treating Teens: A Guide to Adolescent Drug Programs 2003, Drug Strategies, Washington, DC.
14. Godley M.D., Godley S.H., Dennis M.L., Funk R.R., Passetti L.L. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction 2007, 102:81-93.
15. Hernan M.A., Brumback B., Robins J.M. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000, 11:561-570.
16. Hernan M.A., Brumback B.A., Robins J.M. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat. Med. 2002, 21:1689-1709.
17. Hser Y.-I., Grella C., Chou C.-P., Anglin M.D. Relationships between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Eval. Rev. 1998, 22:496-519.
18. Hser Y.I., Anglin M.D., Chou C.P. Reliability of retrospective self-report by heroin addicts. Psychol. Assess. 1992, 4:207-213.
19. Hser Y.I., Anglin M.D., Grella C., Longshore D., Prendergast M.L. Drug treatment careers. A conceptual framework and existing research findings. J. Subst. Abuse Treat. 1997, 14:543-558.
20. Hser Y.I., Grella C.E., Hubbard R.L., Hsieh S.C., Fletcher B.W., Brown B.S., Anglin M.D. An evaluation of drug treatments for adolescents in 4 US cities. Arch. Gen. Psychiatry 2001, 58:689-695.
21. Hser Y.I., Longshore D., Anglin M.D. The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval. Rev. 2007, 31:515-547.
22. Hubbard S.R., Mohammadi M., Schlessinger J. Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem. 1998, 273:11987-11990.
23. Hunter S.B., Griffin B.A., Booth M.S., Ramchand R., McCaffrey D.F. Assessing the generalizability of the CSAT-sponsored GAIN dataset: are the CSAT sites representative of adolescent treatment programs in the U.S.?. J. Subst. Abuse Treat. 2013, 46:238-243.
24. Hunter S.B., Ramchand R., Griffin B.A., Suttorp M.J., McCaffrey D., Morral A. The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use. J. Subst. Abuse Treat. 2012, 43:211-220.
25. Institute of Medicine (U.S.) Improving the Quality of Health Care for Mental and Substance-Use Conditions. Quality Chasm Series. Committee on Crossing the Quality Chasm 2006, National Academies Press, Washington, DC.
26. Jensen C.D., Cushing C.C., Aylward B.S., Craig J.T., Sorell D.M., Steele R.G. Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J. Consult. Clin. Psychol. 2011, 79:433-440.
27. Kaminer Y., Burleson J.A., Burke R.H. Efficacy of outpatient aftercare for adolescents with alcohol use disorders: a randomized controlled study. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:1405-1412.
28. Kim C., Feldman H.I., Joffe M., Tenhave T., Boston R., Apter A.J. Influences of earlier adherence and symptoms on current symptoms: a marginal structural models analysis. J. Allergy Clin. Immunol. 2005, 115:810-814.
29. Li L., Evans E., Hser Y.I. A marginal structural modeling approach to assess the cumulative effect of drug treatment on the later drug use abstinence. J. Drug Issues 2010, 40:221-240.
30. Maddux J.F., Prihoda T.J., Desmond D.P. Treatment fees and retention on methadone maintenance. J. Drug Issues 1994, 24:429-443.
31. McCaffrey D.F., Griffin B.A., Almirall D., Slaughter M.E., Ramchand R. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat. Med. 2013, 32:3388-3414.
32. McGlothlin W.H., Anglin M.D., Wilson B.D. An Evaluation of the California Civil Addict Program (DHEW Publication No. (ADM) 78-558) 1977, U.S. Government Printing Office, Washington, DC.
33. Raghunathan T., Solenberger P., Van Hoewyk J. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv. Methodol. 2002, 27:85-95.
34. Ray G.T., Mertens J.R., Weisner C. The excess medical cost and health problems of family members of persons diagnosed with alcohol or drug problems. Med. Care 2007, 45:116-122.
35. Robins J.M. A new approach to causal inference in mortality studies with sustained exposure periods: application to control of the healthy worker survivor effect. Math. Modelling 1986, 7:1393-1512.
36. Robins J.M. Addendum to "a new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy worker survivor effect". CAMWA 1987, 14:923-945.
37. Robins J.M. Correcting for non-compliance in randomized trials using structural nested mean models. Commun. Stat. Theory Meth. 1994, 23:2379-2412.
38. Robins J.M. Association, causation, and marginal structural models. Synthese 1999, 121:151-179.
39. Robins J.M., Hernan M.A., Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000, 11:550-560.
40. Rubin D. Multiple Imputation for Nonresponse in Surveys 1987, Wiley, New York, NY.
41. Salomé H.J., French M.T., Miller M., McLellan A.T. Estimating the client costs of addiction treatment: first findings from the client drug abuse cost analysis program (Client DATCAP). Drug Alcohol Depend. 2003, 71:195-206.
42. SAMHDA. Other substance abuse measures by client characteristics. (accessed 9.4.13). http://www.icpsr.umich.edu/quicktables/quicksetoptions.do%3FreportKey=33261-0001%3A3.
43. Schafer J. Analysis of Incomplete Multivariate Data 1997, Chapman and Hall/CRC Press, London.
44. Schell T.L., Orlando M., Morral A.R. Dynamic effects among patients' treatment needs, beliefs, and utilization: a prospective study of adolescents in drug treatment. Health Serv. Res. 2005, 40:1128-1147.
45. Scherzer R., Estrella M., Li Y., Choi A.I., Deeks S.G., Grunfeld C., Shlipak M.G. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS 2012, 26:867-875.
46. Schuler M., Griffin B.A., Ramchand R., Almirall D., McCaffrey D. Effectiveness of adolescent substance abuse treatments: is biological drug testing sufficient?. J. Stud. Alcohol Drug. 2014, (in press).
47. Simpson D.D., Joe G.W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993, 30:357-368.
48. Tanner-Smith E.E., Wilson S.J., Lipsey M.W. The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis. J. Subst. Abuse Treat. 2013, 44:145-158.
49. Weisner C., Mertens J., Tam T., Moore C. Factors affecting the initiation of substance abuse treatment in managed care. Addiction 2001, 96:705-716.
50. Williams R.J., Chang S.Y. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin. Psychol. Sci. Pract. 2000, 7:138-166.
51. Winters K.C., Botzet A.M., Fahnhorst T., Stinchfield R., Koskey R. Adolescent substance abuse treatment: a review of evidence-based research. Handbook on the Prevention and Treatment of Substance Abuse in Adolescence 2009, 73-96. Springer, New York. C. Leukefeld, T. Gullotta, M.S. Tindall (Eds.).
52. Witkiewitz K., Marlatt G.A. Relapse prevention for alcohol and drug problems: that was zen, this is tao. Am. Psychol. 2004, 59:224-235.